Ignite Creation Date:
2024-05-06 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05031728
Status:
COMPLETED
Last Update Posted:
2021-09-02
First Post:
2021-08-17
Brief Title:
Cognitive Processing Therapy for Syrian Patients With PTSD
Sponsor:
British University In Egypt
Organization:
British University In Egypt
Study Overview
Official Title:
Cognitive Processing Therapy for the Treatment of Post-Traumatic Stress Disorder in Syrian Patients
Status:
COMPLETED
Status Verified Date:
2021-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CPT4Syrians
Brief Summary:
Background Studies among Syrian refugees showed high prevalence rates of PTSD The objective of the present study was to investigate the effectiveness of Cognitive Processing Therapy CPT in treating patients with posttraumatic stress disorder PTSD using a clinical trial Methods Data will be obtained through interviewing patients seeking for PTSD treatment Patients will be interviewed by a clinician and asked to complete the Clinician-Administered PTSD Scale CAPS-5 Beck Depression Inventory BDI-II Beck Anxiety Inventory BAI Assessments will be conducted at baseline 3- and 12-months posttreatment The primary outcomes will be the scores of CAPS BDI-II and BAI Results we predict that CPT will result in greater reductions in CAPS scores
Detailed Description:
Although individuals with PTSD experience significant suffering disability and a challenging clinical course there are still significant gaps in the evidence addressing effective treatment options Therefore in the current study CPT will determine the effectiveness in treating Syrian patients with PTSD Current study significantly adds to the existing literature It is a novel study in Egypt and adds to the literature
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None